secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001493152-25-019734
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

DSS BioHealth converts Series A Preferred into 60.5M common shares of Impact BioMedical
--------------------------------------------------------------------------------

- DSS BioHealth Security converted its Series A Convertible Preferred Stock into 60,496,041 shares of common stock.
- Conversion was elected under Section 6 of the Certificate of Designation, effective after 75-day holding period.
- The converted shares represent a significant increase in diluted share count, potentially impacting existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225019734/0001493152-25-019734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225019734/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-019734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer